Jade Biosciences, Inc.
- JBIO
- NASDAQ
- Biotechnology
- Autoimmune Disease Biotech
- Anti-APRIL Antibody
$13.47
Today −2.11%Quote Oct 16, 2026, 08:00 PM UTC
−21.41%over the last month
Max drawdown −21.8%From 1-month high −21.4%3 months −31.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$856.7M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$47.83
+255.1% from here
Floor
$13.44
0.2% below price
Where the price sits
4 analysts
Analyst range, low to high
$45.00$55.00
- Price $13.47
- Resistance $14.09
- Consensus $47.83
The price is just above its floor. Analysts' average target sits about 255% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about JBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
55